You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
|
|---|---|
| Published in |
European Heart Journal, August 2011
|
| DOI | 10.1093/eurheartj/ehr334 |
| Pubmed ID | |
| Authors |
Ph. Gabriel Steg, Shamir R. Mehta, J. Wouter Jukema, Gregory Y.H. Lip, C. Michael Gibson, Frantisek Kovar, Petr Kala, Alberto Garcia-Hernandez, Ronny W. Renfurm, Christopher B. Granger |
| Abstract |
To establish the safety, tolerability and most promising regimen of darexaban (YM150), a novel, oral, direct factor Xa inhibitor, for prevention of ischaemic events in acute coronary syndrome (ACS). |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 106 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 13% |
| Researcher | 13 | 12% |
| Student > Bachelor | 13 | 12% |
| Student > Postgraduate | 10 | 9% |
| Student > Ph. D. Student | 8 | 7% |
| Other | 20 | 18% |
| Unknown | 32 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Agricultural and Biological Sciences | 5 | 5% |
| Computer Science | 4 | 4% |
| Chemistry | 3 | 3% |
| Other | 6 | 5% |
| Unknown | 36 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2022.
All research outputs
#4,886,192
of 23,500,709 outputs
Outputs from European Heart Journal
#4,199
of 10,240 outputs
Outputs of similar age
#26,417
of 125,813 outputs
Outputs of similar age from European Heart Journal
#36
of 94 outputs
Altmetric has tracked 23,500,709 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,240 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.9. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,813 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.